-+ 0.00%
-+ 0.00%
-+ 0.00%

Jazz Pharmaceuticals Director Bruce C. Cozadd Reports Sale of $16.24 Million in Common Shares

PUBT·11/10/2026 21:57:54
Listen to the news
Jazz Pharmaceuticals Director Bruce C. Cozadd Reports Sale of $16.24 Million in Common Shares
  • Jazz Pharmaceuticals director Bruce C. Cozadd sold 68,808 ordinary shares on Nov. 6, 2026.
  • He exercised stock options to acquire 86,500 ordinary shares at $136.18 per share the same day.
  • Following the transactions, Cozadd directly owned 357,567 ordinary shares, according to the Nov. 10 filing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193210-26-000032), on November 10, 2026, and is solely responsible for the information contained therein.